Cynata Therapeutics Kicks Off Patient Enrollment

September 14, 2020

Cynata Therapeutics Kicks Off Patient Enrollment

Biotech company Cynata Therapeutics has begun enrolling patients in their mesenchymal COVID-19 (MEND) trial. The study will explore the efficacy of mesenchymal stem cells in adults diagnosed with severe cases of the virus. “MSCs represent a very promising therapeutic approach to a range of important diseases,” commented company CEO Ross MacDonald. Yourway can transport, store, and distribute even the most challenging drug products, making us the ideal logistics partner provider for all clinical trial needs.

Back to Index

Media

Upcoming Events

Precision in Clinical Trials Summit (Boston)

May 6-7, 2024
Hilton Boston Park Plaza

Schedule a Meeting

Global Clinical Trial Innovation, Challenges, and Perspectives

June 6, 2024
Yourway's EU Flagship Depot in Dublin, Ireland

Schedule a Meeting

Media

Articles

Regulatory barriers in cross-border European pharmaceutical transport

Open chat

Hello! How can I help you?